Leveraging digital tools to support recovery from substance use disorder during the COVID-19 pandemic response. 2021

Amy McDonnell, and Courtney MacNeill, and Brittany Chapman, and Nicole Gilbertson, and Megan Reinhardt, and Stephanie Carreiro
Aware Recovery Care, Wallingford, CT 06492, United States of America.

Treatment for substance use disorder (SUD) during the COVID-19 pandemic poses unique challenges, both due to direct effects from the illness, and indirect effects from the physical measures needed to "flatten the curve." Stress, isolation, lack of structure, limited access to physical and mental health care, and changes in treatment paradigms all increase risk of return to drug use events and pose barriers to recovery for people with SUDs. The pandemic has forced treatment providers and facilities to rapidly adapt to address these threats while redesigning their structure to accommodate physical distancing regulations. Digital health interventions can function without the need for physical proximity. Clinicians can use digital health intervention, such as telehealth, wearables, mobile applications, and other remote monitoring devices, to convert in-person care to remote-based care, and they can leverage these tools to address some of the pandemic-specific challenges to treatment. The current pandemic provides the opportunity to rapidly explore the advantages and limitations of these technologies in the care of individuals with SUD.

UI MeSH Term Description Entries
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000076251 Wearable Electronic Devices Electronic implements worn on the body as an implant or as an accessory. Examples include wearable diagnostic devices, wearable ACTIVITY TRACKERS, wearable INFUSION PUMPS, wearable computing devices, SENSORY AIDS, and electronic pest repellents. Wearable Computer,Electronic Skin,Wearable Devices,Wearable Technology,Computer, Wearable,Device, Wearable,Device, Wearable Electronic,Electronic Device, Wearable,Skin, Electronic,Technology, Wearable,Wearable Computers,Wearable Device,Wearable Electronic Device,Wearable Technologies
D000086382 COVID-19 A viral disorder generally characterized by high FEVER; COUGH; DYSPNEA; CHILLS; PERSISTENT TREMOR; MUSCLE PAIN; HEADACHE; SORE THROAT; a new loss of taste and/or smell (see AGEUSIA and ANOSMIA) and other symptoms of a VIRAL PNEUMONIA. In severe cases, a myriad of coagulopathy associated symptoms often correlating with COVID-19 severity is seen (e.g., BLOOD COAGULATION; THROMBOSIS; ACUTE RESPIRATORY DISTRESS SYNDROME; SEIZURES; HEART ATTACK; STROKE; multiple CEREBRAL INFARCTIONS; KIDNEY FAILURE; catastrophic ANTIPHOSPHOLIPID ANTIBODY SYNDROME and/or DISSEMINATED INTRAVASCULAR COAGULATION). In younger patients, rare inflammatory syndromes are sometimes associated with COVID-19 (e.g., atypical KAWASAKI SYNDROME; TOXIC SHOCK SYNDROME; pediatric multisystem inflammatory disease; and CYTOKINE STORM SYNDROME). A coronavirus, SARS-CoV-2, in the genus BETACORONAVIRUS is the causative agent. 2019 Novel Coronavirus Disease,2019 Novel Coronavirus Infection,2019-nCoV Disease,2019-nCoV Infection,COVID-19 Pandemic,COVID-19 Pandemics,COVID-19 Virus Disease,COVID-19 Virus Infection,Coronavirus Disease 2019,Coronavirus Disease-19,SARS Coronavirus 2 Infection,SARS-CoV-2 Infection,Severe Acute Respiratory Syndrome Coronavirus 2 Infection,COVID19,2019 nCoV Disease,2019 nCoV Infection,2019-nCoV Diseases,2019-nCoV Infections,COVID 19,COVID 19 Pandemic,COVID 19 Virus Disease,COVID 19 Virus Infection,COVID-19 Virus Diseases,COVID-19 Virus Infections,Coronavirus Disease 19,Disease 2019, Coronavirus,Disease, 2019-nCoV,Disease, COVID-19 Virus,Infection, 2019-nCoV,Infection, COVID-19 Virus,Infection, SARS-CoV-2,Pandemic, COVID-19,SARS CoV 2 Infection,SARS-CoV-2 Infections,Virus Disease, COVID-19,Virus Infection, COVID-19
D017216 Telemedicine Delivery of health services via remote telecommunications. This includes interactive consultative and diagnostic services. Tele-Care,Tele-ICU,Tele-Intensive Care,Tele-Referral,Telecare,Virtual Medicine,Mobile Health,Telehealth,eHealth,mHealth,Health, Mobile,Medicine, Virtual,Tele Care,Tele ICU,Tele Intensive Care,Tele Referral,Tele-Referrals
D019966 Substance-Related Disorders Disorders related to substance use or abuse. Chemical Dependence,Drug Abuse,Drug Addiction,Drug Dependence,Drug Habituation,Drug Use Disorder,Drug Use Disorders,Organic Mental Disorders, Substance-Induced,Substance Abuse,Substance Dependence,Substance Related Disorder,Substance Use,Substance Use Disorder,Substance Use Disorders,Prescription Drug Abuse,Substance Addiction,Abuse, Drug,Abuse, Prescription Drug,Abuse, Substance,Addiction, Drug,Addiction, Substance,Chemical Dependences,Dependence, Chemical,Dependence, Drug,Dependence, Substance,Dependences, Chemical,Disorder, Drug Use,Disorder, Substance Related,Disorder, Substance Use,Disorders, Substance Related,Drug Abuse, Prescription,Habituation, Drug,Organic Mental Disorders, Substance Induced,Related Disorder, Substance,Related Disorders, Substance,Substance Abuses,Substance Uses,Use, Substance
D063731 Mobile Applications Computer programs or software installed on mobile electronic devices which support a wide range of functions and uses which include television, telephone, video, music, word processing, and Internet service. Mobile Apps,Smartphone Apps,Portable Electronic Applications,Portable Electronic Apps,Portable Software Applications,Portable Software Apps,App, Mobile,App, Portable Electronic,App, Portable Software,App, Smartphone,Application, Mobile,Application, Portable Electronic,Application, Portable Software,Applications, Mobile,Apps, Mobile,Apps, Smartphone,Electronic App, Portable,Electronic Application, Portable,Mobile App,Mobile Application,Portable Electronic App,Portable Electronic Application,Portable Software App,Portable Software Application,Smartphone App,Software App, Portable,Software Application, Portable

Related Publications

Amy McDonnell, and Courtney MacNeill, and Brittany Chapman, and Nicole Gilbertson, and Megan Reinhardt, and Stephanie Carreiro
October 2020, JMIR mental health,
Amy McDonnell, and Courtney MacNeill, and Brittany Chapman, and Nicole Gilbertson, and Megan Reinhardt, and Stephanie Carreiro
December 2021, Drug and alcohol dependence,
Amy McDonnell, and Courtney MacNeill, and Brittany Chapman, and Nicole Gilbertson, and Megan Reinhardt, and Stephanie Carreiro
January 2021, Journal of psychiatry and brain science,
Amy McDonnell, and Courtney MacNeill, and Brittany Chapman, and Nicole Gilbertson, and Megan Reinhardt, and Stephanie Carreiro
January 2023, Substance use & misuse,
Amy McDonnell, and Courtney MacNeill, and Brittany Chapman, and Nicole Gilbertson, and Megan Reinhardt, and Stephanie Carreiro
January 2021, Journal of substance abuse treatment,
Amy McDonnell, and Courtney MacNeill, and Brittany Chapman, and Nicole Gilbertson, and Megan Reinhardt, and Stephanie Carreiro
January 2021, Frontiers in digital health,
Amy McDonnell, and Courtney MacNeill, and Brittany Chapman, and Nicole Gilbertson, and Megan Reinhardt, and Stephanie Carreiro
July 2020, Psychiatry research,
Amy McDonnell, and Courtney MacNeill, and Brittany Chapman, and Nicole Gilbertson, and Megan Reinhardt, and Stephanie Carreiro
March 2022, The International journal on drug policy,
Amy McDonnell, and Courtney MacNeill, and Brittany Chapman, and Nicole Gilbertson, and Megan Reinhardt, and Stephanie Carreiro
January 2023, Therapie,
Amy McDonnell, and Courtney MacNeill, and Brittany Chapman, and Nicole Gilbertson, and Megan Reinhardt, and Stephanie Carreiro
January 2021, Drug and alcohol dependence,
Copied contents to your clipboard!